title: Lack of emergence of genotypic resistance to stavudine after 2 years of monotherapy.
authors.forename: V
authors.initials: V
authors.lastname: Soriano
authors.forename: U
authors.initials: U
authors.lastname: Dietrich
authors.forename: N
authors.initials: N
authors.lastname: Villalba
authors.forename: A
authors.initials: A
authors.lastname: Immelmann
authors.forename: A
authors.initials: A
authors.lastname: Gil-Aguado
authors.forename: S
authors.initials: S
authors.lastname: Echevarría
authors.forename: B
authors.initials: B
authors.lastname: Clotet
authors.forename: I
authors.initials: I
authors.lastname: Ocaña
authors.forename: J M
authors.initials: JM
authors.lastname: Santamaría
authors.forename: E
authors.initials: E
authors.lastname: Bouza
authors.forename: V
authors.initials: V
authors.lastname: Barona
authors.forename: J M
authors.initials: JM
authors.lastname: Gatell
authors.forename: J
authors.initials: J
authors.lastname: González-Lahoz
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy* / Q000235:genetics; D015497:HIV-1; D006801:Humans; D009154:Mutation; D010865:Pilot Projects; D018119:Stavudine / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D018119:Stavudine